What is the current stock price of Apyx Medical Corporation (APYX)?

As of the latest market data, Apyx Medical Corporation (APYX) is trading at $3.96. The stock has seen a loss of -1.00% today.

Does Apyx Medical Corporation (APYX) pay a dividend?

Based on current data, Apyx Medical Corporation does not have a confirmed active dividend policy.

What is the market cap of Apyx Medical Corporation?

The current market capitalization of Apyx Medical Corporation (APYX) is approximately unavailable.

APYX

Apyx Medical Corporation·Healthcare

3.96

1.000%(−0.04)

Close Price

4.35

9.848%(+0.39)

After Hours

Last Updated: — ET

52W L: $0.8252W H: $4.50

APYX NEWS

prnewswire.com

Apr 1

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin. CLEARWATER, Fla.

seekingalpha.com

Mar 10

Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

globenewswire.com

Mar 10

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025.

globenewswire.com

Feb 18

Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference

CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in The Citizens Life Sciences Conference on Wednesday, March 11, 2026, in Miami, FL.

gurufocus.com

Jan 23

Chuck Royce's Recent Transaction with Apyx Medical Corp: An In-Depth Analysis

Overview of the Recent Transaction On December 31, 2025, Chuck Royce (Trades, Portfolio), a renowned figure in small-cap investing, made a notable transaction i

globenewswire.com

Jan 12

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

CLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2025.

Company Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Sector

Healthcare

Industry

Medical - Devices

Employees

220

IPO Date

2019-01-02

Beta

1.54

Websitewww.apyxmedical.com↗